awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33648955-E8242C79-091E-4484-A069-8FE654583EB1
Q33648955-E8242C79-091E-4484-A069-8FE654583EB1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33648955-E8242C79-091E-4484-A069-8FE654583EB1
Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma.
P2860
Q33648955-E8242C79-091E-4484-A069-8FE654583EB1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33648955-E8242C79-091E-4484-A069-8FE654583EB1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d07ec08825935e78aa7d63194e3621d854fba19d
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.